For some of the many mothers who experience postpartum depression, therapy and standard antidepressants can alleviate symptoms. But for others, those treatments are slow to provide relief. Now the FDA has approved the first drug specifically intended to treat the illness. Amna Nawaz talks to Dr. Samantha Meltzer-Brody, director of the University of North Carolina’s perinatal psychiatry program.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts